Literature DB >> 16500171

Walking capacity in mild to moderate Parkinson's disease.

Colleen G Canning1, Louise Ada, Justin J Johnson, Stephanie McWhirter.   

Abstract

OBJECTIVES: To examine walking capacity in people with mild to moderate Parkinson's disease (PD), specifically, to determine whether spatiotemporal abnormalities observed when people with PD walk over short distances are exacerbated over longer distances and whether these and other motor impairments affect walking capacity.
DESIGN: Descriptive study comparing participants with PD and healthy participants.
SETTING: University laboratory. PARTICIPANTS: Sixteen participants (mean age, 65y) with mild to moderate PD (stages 1-3 of the Hoehn and Yahr rating scale) were tested "on" medication. Twenty-two healthy participants (mean age, 66y) formed a control group.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Walking capacity was quantified as the distance walked in the 6-minute walk test (6MWT), hypokinesia during walking was quantified as "fast-as-possible" velocity over 8m, hypokinesia during turning was quantified as the time taken to complete a 360 degrees turn in standing, automaticity was quantified as velocity during dual-task walking expressed as a percentage of velocity during single-task walking over 8m, and muscle strength was quantified as peak isometric knee extensor torque.
RESULTS: The PD group covered less distance (P=.01) in the 6MWT than the control group. Although both groups recorded similar fast-as-possible walking velocities, the PD group walked at only 76% of their fast-as-possible velocity during the 6MWT compared with 84% for the control group (P=.002). In the PD group, 94% of the variance in walking capacity was accounted for by hypokinesia during walking and turning as well as strength (P<.001).
CONCLUSIONS: Even when people with PD are capable of walking at velocities comparable to healthy controls, they do not sustain this velocity over longer distances. Training that targets high velocities warrants investigation as a remediation technique.

Entities:  

Mesh:

Year:  2006        PMID: 16500171     DOI: 10.1016/j.apmr.2005.11.021

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  25 in total

1.  Energy cost of spontaneous walking in Parkinson's disease patients.

Authors:  Martina A Maggioni; Arsenio Veicsteinas; Susanna Rampichini; Emiliano Cè; Raffaello Nemni; Giulio Riboldazzi; Giampiero Merati
Journal:  Neurol Sci       Date:  2011-11-01       Impact factor: 3.307

2.  Reference equation for 6-minute walk in individuals with Parkinson disease.

Authors:  Michael J Falvo; Gammon M Earhart
Journal:  J Rehabil Res Dev       Date:  2009

3.  Maximum Step Length Test Performance in People With Parkinson Disease: A Cross-sectional Study.

Authors:  Ryan P Duncan; Marie E McNeely; Gammon M Earhart
Journal:  J Neurol Phys Ther       Date:  2017-10       Impact factor: 3.649

4.  Metabolic and kinematic parameters during walking with poles in Parkinson's disease.

Authors:  Francesca Nardello; F Bombieri; M Tinazzi; F Schena; B Pellegrini
Journal:  J Neurol       Date:  2017-07-10       Impact factor: 4.849

5.  Task-oriented circuit training combined with aerobic training improves motor performance and balance in people with Parkinson's Disease.

Authors:  Fatih Soke; Arzu Guclu-Gunduz; Bilge Kocer; Isil Fidan; Pembe Keskinoglu
Journal:  Acta Neurol Belg       Date:  2019-11-18       Impact factor: 2.396

6.  Profile of functional limitations and task performance among people with early- and middle-stage Parkinson disease.

Authors:  Margaret Schenkman; Terry Ellis; Cory Christiansen; Anna E Barón; Linda Tickle-Degnen; Deborah A Hall; Robert Wagenaar
Journal:  Phys Ther       Date:  2011-07-21

7.  Are the average gait speeds during the 10meter and 6minute walk tests redundant in Parkinson disease?

Authors:  Ryan P Duncan; Stephanie A Combs-Miller; Marie E McNeely; Abigail L Leddy; James T Cavanaugh; Leland E Dibble; Terry D Ellis; Matthew P Ford; K Bo Foreman; Gammon M Earhart
Journal:  Gait Posture       Date:  2016-11-22       Impact factor: 2.840

8.  Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease.

Authors:  Lisa M Shulman; Leslie I Katzel; Frederick M Ivey; John D Sorkin; Knachelle Favors; Karen E Anderson; Barbara A Smith; Stephen G Reich; William J Weiner; Richard F Macko
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

Review 9.  Long-term effects of exercise and physical therapy in people with Parkinson disease.

Authors:  Margaret K Mak; Irene S Wong-Yu; Xia Shen; Chloe L Chung
Journal:  Nat Rev Neurol       Date:  2017-10-13       Impact factor: 42.937

10.  Exercise therapy for prevention of falls in people with Parkinson's disease: a protocol for a randomised controlled trial and economic evaluation.

Authors:  Colleen G Canning; Cathie Sherrington; Stephen R Lord; Victor S C Fung; Jacqueline C T Close; Mark D Latt; Kirsten Howard; Natalie E Allen; Sandra D O'Rourke; Susan M Murray
Journal:  BMC Neurol       Date:  2009-01-22       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.